| Identification of mutations in members of the connexin gene family as a cause of nonsyndromic deafness in Taiwan JJ Yang, SH Huang, KH Chou, PJ Liao, CC Su, SY Li Audiology and Neurotology 12 (3), 198-208, 2007 | 105 | 2007 |
| Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality M Kitagawa, PJ Liao, KH Lee, J Wong, SC Shang, N Minami, ... Nature communications 8 (1), 2200, 2017 | 70 | 2017 |
| Opposing activities of Aurora B kinase and B56-PP2A phosphatase on MKlp2 determine abscission timing SYS Fung, M Kitagawa, PJ Liao, J Wong, SH Lee Current Biology 27 (1), 78-86, 2017 | 30 | 2017 |
| Expression patterns of connexin 29 (GJE1) in mouse and rat cochlea JJ Yang, PJ Liao, CC Su, SY Li Biochemical and Biophysical Research Communications 338 (2), 723-728, 2005 | 24 | 2005 |
| Structural model of human PORCN illuminates disease-associated variants and drug-binding sites J Yu, PJ Liao, W Xu, JR Jones, DB Everman, H Flanagan-Steet, TH Keller, ... Journal of cell science 134 (24), jcs259383, 2021 | 20 | 2021 |
| The tumor suppressor Cdkn3 is required for maintaining the proper number of centrosomes by regulating the centrosomal stability of Mps1 V Srinivas, M Kitagawa, J Wong, PJ Liao, SH Lee Cell reports 13 (8), 1569-1577, 2015 | 19 | 2015 |
| Discovery of the cancer cell selective dual acting anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl) acrylonitrile (A131) CS See, M Kitagawa, PJ Liao, KH Lee, J Wong, SH Lee, BW Dymock European Journal of Medicinal Chemistry 156, 344-367, 2018 | 14 | 2018 |
| A Ras-LSD1 axis activates PI3K signaling through PIK3IP1 suppression K Lee, M Kitagawa, PJ Liao, DM Virshup, SH Lee Oncogenesis 9 (1), 2, 2020 | 8 | 2020 |
| Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl) acrylonitrile (A131) are orally efficacious in a mouse model of resistant … CS See, M Kitagawa, PJ Liao, KH Lee, J Wong, SH Lee, BW Dymock Bioorganic & Medicinal Chemistry Letters 29 (2), 216-219, 2019 | 3 | 2019 |
| Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality L Dai, N Prabhu, GK Diam, R Sobota, A Larsson, P Nordlund, ... | | 2017 |
